Rab11FIP4 in Hepatocellular carcinoma (HCC)

  • Upregulation of Rab11FIP4 has been reported in Hepatocellular carcinoma tissues and cell lines
  • Expression of Rab11FIP4 correlates with a worse/poor prognosis and resistance to chemotherapy
  • Rab11FIP4 can be involved in the proliferation, migration, invasion, and metastasis of HCC tumor cells.
  • A recent study shows that Rab11‐FIP4 enhances resistance to sorafenib therapy.

Was this post helpful?

Author: admin

Leave a Reply

Your email address will not be published. Required fields are marked *